First interim analysis of SWOG S1823: Operating characteristics of circulating microRNA 371a-3p (miR371) in predicting active germ cell malignancy (aGCM) in patients (pts) with early-stage testicular cancer.

Lucia Nappi; Sarah Colby; Robert W. Hamilton; Andrea Harzstark; Nabil Adra; Siamak Daneshmand; Christopher W. Ryan; Scott Eggener; Chunkit Fung; Rebecca Johnson; Seth P. Lerner; Kathryn B. Arnold; Banu Arun; James M. Rae; CHARLES D. BLANKE; Michael LeBlanc; Wendy R. Parulekar; L Einhorn; Christian Kollmannsberger; Craig R. Nichols; on behalf of the SWOG S1823 / CCTG GCC.1 Investigators

doi:10.1200/jco.2026.44.17_suppl.lba5003

No abstract yet

We only have this paper's title and publication details.

Read it at the source

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

Evaluates miR371 as a biomarker for detecting active germ cell malignancy in patients with early-stage testicular cancer, indicating potential clinical utility.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Nappi et al. (2026) studied this question.

synapsesocial.com/papers/6a226835763171746d546c5b https://doi.org/10.1200/jco.2026.44.17_suppl.lba5003

View at Publisher

Ask AI

Bookmark

Share

First interim analysis of SWOG S1823: Operating characteristics of circulating microRNA 371a-3p (miR371) in predicting active germ cell malignancy (aGCM) in patients (pts) with early-stage testicular cancer.

No abstract yet

Ask about this paper

Implication

Discussion

Cite This Study

First interim analysis of SWOG S1823: Operating characteristics of circulating microRNA 371a-3p (miR371) in predicting active germ cell malignancy (aGCM) in patients (pts) with early-stage testicular cancer.

No abstract yet

Ask about this paper

Implication

Discussion

Cite This Study

Keep reading

Keep reading